GR3025678T3 - Glutamine in the treatment of impaired host defences - Google Patents

Glutamine in the treatment of impaired host defences

Info

Publication number
GR3025678T3
GR3025678T3 GR970403327T GR970403327T GR3025678T3 GR 3025678 T3 GR3025678 T3 GR 3025678T3 GR 970403327 T GR970403327 T GR 970403327T GR 970403327 T GR970403327 T GR 970403327T GR 3025678 T3 GR3025678 T3 GR 3025678T3
Authority
GR
Greece
Prior art keywords
glutamine
treatment
host defences
impaired host
gut
Prior art date
Application number
GR970403327T
Other languages
English (en)
Inventor
Robert J Smith
Douglas W Wilmore
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23419606&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3025678(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Publication of GR3025678T3 publication Critical patent/GR3025678T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Packaging Of Machine Parts And Wound Products (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Looms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Seasonings (AREA)
GR970403327T 1989-06-02 1997-12-16 Glutamine in the treatment of impaired host defences GR3025678T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36083989A 1989-06-02 1989-06-02

Publications (1)

Publication Number Publication Date
GR3025678T3 true GR3025678T3 (en) 1998-03-31

Family

ID=23419606

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970403327T GR3025678T3 (en) 1989-06-02 1997-12-16 Glutamine in the treatment of impaired host defences

Country Status (16)

Country Link
EP (1) EP0401056B2 (el)
JP (4) JP3068644B2 (el)
KR (1) KR0178799B1 (el)
AT (1) ATE160089T1 (el)
AU (1) AU641403B2 (el)
DE (1) DE69031694T3 (el)
DK (1) DK0401056T4 (el)
ES (1) ES2111529T5 (el)
FI (1) FI915677A0 (el)
GR (1) GR3025678T3 (el)
HU (1) HU220214B (el)
IL (1) IL94549A (el)
NO (1) NO914730D0 (el)
PT (1) PT94223B (el)
WO (1) WO1990014823A1 (el)
ZA (1) ZA904151B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
JPH0569836U (ja) * 1992-02-25 1993-09-21 松下電工株式会社 ピアノハンドル式スイッチ
US5438075A (en) 1993-03-30 1995-08-01 Skubitz; Keith M. Oral glutamine to reduce stomatitis
US6001878A (en) * 1994-01-11 1999-12-14 Van Leeuwen; Paulus Aloisius Marie Method of treating disorders of the animal or human body by administering amino acids
DE10057290B4 (de) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
GB0114419D0 (en) * 2001-06-13 2001-08-08 Mars Uk Ltd Health food
JP5473190B2 (ja) * 2003-10-16 2014-04-16 ネステク ソシエテ アノニム 化学療法又は放射線療法の副作用に対する栄養組成物
KR101487852B1 (ko) * 2006-12-15 2015-01-29 티마 파운데이션 신규조성물 및 그 용도
US8633192B2 (en) 2006-12-15 2014-01-21 Tima Foundation Compositions and uses thereof
EP2612560A1 (en) 2012-01-09 2013-07-10 N.V. Nutricia Glutamine enriched nutritional composition for preterm infants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction

Also Published As

Publication number Publication date
JP2000186035A (ja) 2000-07-04
HU220214B (hu) 2001-11-28
JPH05500655A (ja) 1993-02-12
ES2111529T5 (es) 2007-11-16
JP3113878B2 (ja) 2000-12-04
JP3113876B2 (ja) 2000-12-04
KR920700629A (ko) 1992-08-10
EP0401056B1 (en) 1997-11-12
JP3068644B2 (ja) 2000-07-24
DK0401056T4 (da) 2007-07-16
ES2111529T3 (es) 1998-03-16
JP3113877B2 (ja) 2000-12-04
NO914730D0 (no) 1991-12-02
EP0401056A2 (en) 1990-12-05
IL94549A (en) 1996-08-04
DK0401056T3 (da) 1998-07-27
EP0401056A3 (en) 1991-09-25
JP2000198733A (ja) 2000-07-18
AU641403B2 (en) 1993-09-23
IL94549A0 (en) 1991-03-10
AU5827190A (en) 1991-01-07
HUT61193A (en) 1992-12-28
KR0178799B1 (ko) 1999-03-20
DE69031694T2 (de) 1998-03-12
PT94223A (pt) 1991-02-08
PT94223B (pt) 1997-04-30
WO1990014823A1 (en) 1990-12-13
JP2000186034A (ja) 2000-07-04
DE69031694D1 (de) 1997-12-18
ATE160089T1 (de) 1997-11-15
FI915677A0 (fi) 1991-12-02
EP0401056B2 (en) 2007-06-13
ZA904151B (en) 1991-03-27
DE69031694T3 (de) 2007-10-18

Similar Documents

Publication Publication Date Title
DK0862865T3 (da) Behandling af tobak
EP0434333A3 (en) Tobacco extract treatment process
HUT67945A (en) Parathyroid hormon and raloxifene for increasing bone mass
EP0476054A4 (en) Method for treating viral infection
GR3025678T3 (en) Glutamine in the treatment of impaired host defences
ZA896864B (en) Method and composition for the treatment and prevention of viral infections
GB9226900D0 (en) Mucus extractor
EP0610444A4 (en) METHOD OF TREATING VIRAL DISEASES.
GB8901759D0 (en) Method of and apparatus for sorting and/or confirming the identity of gems
EP0608212A4 (en) PROCESS FOR TREATING VIRAL INFECTIONS.
NO891494D0 (no) Sett eller spill for komposisjon av tall, former og moenstre.
IL96052A0 (en) Method for the prevention and treatment of bovine mastitis
GB2238740B (en) Sand treatment method and apparatus
CA2057055A1 (en) Method of treating catabolic, gut-associated pathological processes and impaired host defenses
DE59002951D1 (de) Verfahren und vorrichtung zur vakuumbehandlung von metallen.
JPS6431983A (en) Metal treatment composition and method
WO1998006431A3 (en) Method for treating diabetes
GB2255718B (en) Pharmaceutical composition for treating bacterial and / or viral infection
CA2214036A1 (en) Tobacco treatment
ZA907103B (en) Recovery of volatile metals from fume condensate
ATE95250T1 (de) Verfahren und vorrichtung zur vakuumbehandlung von metallen.
PL269183A1 (en) Electroslag remelting method
ZA902032B (en) Compositions and methods for treating viral infections
SU1568981A1 (ru) Cпocoб xиpуpгичeckoгo лeчehия дakpиoциctиta
SU1568982A1 (ru) Cпocoб xиpуpгичeckoгo лeчehия дakpиoциctиta